Works matching IS 11750561 AND DT 2023 AND VI 24 AND IP 5
Results: 15
Capturing the Diversity of Dermatology—What's in a Name?
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 675, doi. 10.1007/s40257-023-00800-9
- By:
- Publication type:
- Article
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 849, doi. 10.1007/s40257-023-00812-5
- By:
- Publication type:
- Article
Authors' Reply to Chen and Chen: Comment on: "Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Comment on: "Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Atopic Dermatitis Across Shades of Skin.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 731, doi. 10.1007/s40257-023-00797-1
- By:
- Publication type:
- Article
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 753, doi. 10.1007/s40257-023-00793-5
- By:
- Publication type:
- Article
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 787, doi. 10.1007/s40257-023-00791-7
- By:
- Publication type:
- Article
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 765, doi. 10.1007/s40257-023-00790-8
- By:
- Publication type:
- Article
Targeting Inflammation in Acne: Current Treatments and Future Prospects.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 681, doi. 10.1007/s40257-023-00789-1
- By:
- Publication type:
- Article
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 837, doi. 10.1007/s40257-023-00788-2
- By:
- Publication type:
- Article
Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 799, doi. 10.1007/s40257-023-00787-3
- By:
- Publication type:
- Article
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 695, doi. 10.1007/s40257-023-00786-4
- By:
- Publication type:
- Article
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet's Syndrome.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 809, doi. 10.1007/s40257-023-00783-7
- By:
- Publication type:
- Article
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 821, doi. 10.1007/s40257-023-00782-8
- By:
- Publication type:
- Article
Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 721, doi. 10.1007/s40257-023-00765-9
- By:
- Publication type:
- Article